Compare WHLR & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WHLR | SCNI |
|---|---|---|
| Founded | 2011 | 2003 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2M | 4.6M |
| IPO Year | 2012 | N/A |
| Metric | WHLR | SCNI |
|---|---|---|
| Price | $2.73 | $0.94 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 5.1M | 41.7K |
| Earning Date | 11-06-2025 | 11-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 61.36 | 0.26 |
| Revenue | ★ $101,834,000.00 | $1,147,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $0.05 | $4.55 |
| Revenue Growth | N/A | ★ 303.87 |
| 52 Week Low | $2.62 | $0.86 |
| 52 Week High | $9,590.00 | $6.18 |
| Indicator | WHLR | SCNI |
|---|---|---|
| Relative Strength Index (RSI) | 47.64 | 38.13 |
| Support Level | $2.62 | $1.14 |
| Resistance Level | $6.85 | $1.26 |
| Average True Range (ATR) | 0.81 | 0.10 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 25.09 | 13.13 |
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.